Spanish drugmaker Grifols swung to a first-quarter net profit of 21 million euros ($23 million) from a year-ago loss, and ...

Grifols SA shares fell after short-seller Gotham City Research released a new report accusing the healthcare company of ...

A well-publicized short bet by General Industrial Partners on Spanish company Grifols SA helped the hedge fund earn ...

Deutsche Bank raised the price target for the Grifols SA ADR (NASDAQ:GRFS) stock from “a Hold” to “a Sell”. The rating was released on March 12, 2024, according to finviz.

Grifols SA releases earnings for Q1 on May 14.Wall Street analysts are expecting earnings per share of €0.098.Watch Grifols SA stock price in ...

Grifols reveals earnings for Q1 on May 14.Wall Street analysts are expecting earnings per share of $0.106.Follow Grifols stock price in real-time ...

Alzheimer’s Disease is a relentless condition that strips people of their memories, their autonomy, and eventually their ...

Grifols has experienced a significant 43% decline in stock price in 2024 following a bearish report from Gotham. Read why I'm neutral on GRFS stock.

Grifols' market value has shed billions of euros since short-sheller Gotham City Research released three reports in early January accusing the company of overstating earnings and understating debt.

BARCELONA, Spain, April 18, 2024 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today officially ...

In just the last decade, more than 1,500 jobs have been added at two of the biggest companies in the area, Grifols and Novo Nordisk. A closer look shows us how the area is embracing this type of ...